English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23780653      線上人數 : 673
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34581


    標題: Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer
    作者: Yeh, Hsin-Chih
    Su, Chia-Cheng
    Wu, Yen-Hsuan
    Lee, Cheng Hsueh
    Bao, Bo-Ying
    Cheng, Wei-Chung
    Wang, Shu-Chi
    Liu, Po-Len
    Chiu, Chien-Chih
    Chuu, Chih-Pin
    Ke, Chien-Chih
    Wu, Hsin-En
    Chen, Yuan-Ru
    Chung, Wei-Ju
    Huang, Shu-Pin
    Li, Chia-Yang
    貢獻者: Kaohsiung Medical University
    Kaohsiung Medical University Hospital
    Kaohsiung Medical University
    Kaohsiung Medical University
    Kaohsiung Medical University
    Kaohsiung Municipal Ta-Tung Hospital
    Chi Mei Hospital
    Chia Nan University of Pharmacy & Science
    China Medical University Taiwan
    China Medical University Taiwan
    China Medical University Hospital - Taiwan
    Asia University Taiwan
    China Medical University Taiwan
    China Medical University Taiwan
    Kaohsiung Medical University
    Kaohsiung Medical University
    Kaohsiung Medical University
    National Health Research Institutes - Taiwan
    Kaohsiung Medical University
    Kaohsiung Medical University
    Kaohsiung Medical University
    關鍵字: cell-cycle arrest
    apoptosis
    therapy
    agent
    model
    mcf-7
    line
    日期: 2022
    上傳時間: 2023-12-11 13:59:00 (UTC+8)
    出版者: ELSEVIER
    摘要: 3-bromopyruvic acid (3-BP), a small molecule alkylating agent, has been emerged as a glycolytic inhibitor with anticancer activities. However, the effects of 3-BP on the growth and metastasis in prostate cancer have not been well investigated. Here we investigated the anti-cancer effects of 3-BP on prostate cancer in vitro and in vivo. Cell growth, apoptosis, migration, motility, and invasion were examined. The tumor growth ability was determined using a xenograft murine model. Transcriptome analysis using RNA-seq was performed to explore the mechanism of action of 3-BP. Our experimental results showed that 3-BP effectively inhibits prostate cancer cell growth, especially in castration-resistant prostate cancer (CRPC) cells. Moreover, 3-BP induces apoptosis and suppresses cell migration, motility, epithelial-mesenchymal transition (EMT), and invasion in CRPC cells. In addition, 3-BP also attenuates tumor growth in a xenograft murine model. Through transcriptome analysis using RNA-seq, 3-BP significantly regulates the cell cycle pathway and decreases the expression of downstream cycle cycle-associated genes in CRPC cells. The results of cell cycle analysis indicated that 3-BP arrests cell cycle progression at G2/M in CRPC cells. These results suggest that 3-BP has the potential in inhibiting CRPC progression and might be a promising drug for CRPC treatment.
    關聯: EUROPEAN JOURNAL OF PHARMACOLOGY, v.923, n.CB2, pp.CC2, pp.-,
    顯示於類別:[行政單位] 123

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML67檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋